Denali Therapeutics IncNASDAQ:DNLI
- LAST PRICE20.5100
- TODAY'S CHANGE (%)0.2700 (1.3340%)
- Bid / Lots19.9500/ 1
- Ask / Lots21.2200/ 1
- Open / Previous Close20.3000 / 20.2400
- Day Range
- 52 Week Range
- Volume750,216
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DNLI |
|---|---|---|
| 09:32 ET | 32429 | 20.24 |
| 09:34 ET | 4269 | 20 |
| 09:36 ET | 1208 | 20 |
| 09:38 ET | 400 | 20.02 |
| 09:41 ET | 1340 | 20.05 |
| 09:43 ET | 1409 | 20 |
| 09:45 ET | 300 | 19.99 |
| 09:50 ET | 200 | 20 |
| 09:52 ET | 228 | 20.03 |
| 09:54 ET | 1300 | 20.09 |
| 09:56 ET | 1136 | 20.11 |
| 09:57 ET | 900 | 20.15 |
| 10:01 ET | 100 | 20.17 |
| 10:06 ET | 2230 | 20.22 |
| 10:10 ET | 200 | 20.145 |
| 10:12 ET | 200 | 20.12 |
| 10:14 ET | 300 | 20.12 |
| 10:15 ET | 100 | 20.14 |
| 10:19 ET | 200 | 20.11 |
| 10:21 ET | 3424 | 20.13 |
| 10:24 ET | 300 | 20.14 |
| 10:26 ET | 2110 | 20.14 |
| 10:28 ET | 100 | 20.16 |
| 10:30 ET | 513 | 20.1735 |
| 10:33 ET | 400 | 20.15 |
| 10:37 ET | 700 | 20.17 |
| 10:39 ET | 400 | 20.13 |
| 10:42 ET | 931 | 20.14 |
| 10:44 ET | 1750 | 20.19 |
| 10:46 ET | 100 | 20.2 |
| 10:50 ET | 730 | 20.22 |
| 10:51 ET | 1023 | 20.251 |
| 10:53 ET | 1873 | 20.31 |
| 10:55 ET | 300 | 20.35 |
| 10:57 ET | 100 | 20.345 |
| 11:00 ET | 300 | 20.34 |
| 11:02 ET | 400 | 20.33 |
| 11:04 ET | 200 | 20.29 |
| 11:06 ET | 500 | 20.29 |
| 11:08 ET | 308 | 20.27 |
| 11:09 ET | 900 | 20.25 |
| 11:11 ET | 861 | 20.255 |
| 11:13 ET | 1700 | 20.305 |
| 11:15 ET | 300 | 20.31 |
| 11:18 ET | 200 | 20.32 |
| 11:20 ET | 100 | 20.31 |
| 11:22 ET | 2691 | 20.37 |
| 11:24 ET | 600 | 20.39 |
| 11:26 ET | 1356 | 20.37 |
| 11:27 ET | 300 | 20.36 |
| 11:29 ET | 400 | 20.36 |
| 11:31 ET | 3500 | 20.29 |
| 11:33 ET | 700 | 20.305 |
| 11:36 ET | 1720 | 20.355 |
| 11:38 ET | 922 | 20.37 |
| 11:40 ET | 400 | 20.355 |
| 11:42 ET | 1888 | 20.36 |
| 11:44 ET | 400 | 20.35 |
| 11:45 ET | 1847 | 20.42 |
| 11:47 ET | 800 | 20.41 |
| 11:49 ET | 423 | 20.42 |
| 11:51 ET | 444 | 20.4342 |
| 11:54 ET | 2619 | 20.44 |
| 11:56 ET | 1989 | 20.47 |
| 11:58 ET | 1688 | 20.47 |
| 12:00 ET | 1343 | 20.5257 |
| 12:02 ET | 100 | 20.515 |
| 12:03 ET | 846 | 20.515 |
| 12:05 ET | 1430 | 20.48 |
| 12:07 ET | 1027 | 20.51 |
| 12:09 ET | 400 | 20.53 |
| 12:12 ET | 500 | 20.54 |
| 12:14 ET | 934 | 20.56 |
| 12:16 ET | 2104 | 20.57 |
| 12:18 ET | 200 | 20.57 |
| 12:20 ET | 300 | 20.57 |
| 12:21 ET | 2587 | 20.535 |
| 12:23 ET | 200 | 20.535 |
| 12:25 ET | 2197 | 20.64 |
| 12:27 ET | 200 | 20.64 |
| 12:30 ET | 1200 | 20.71 |
| 12:32 ET | 300 | 20.7 |
| 12:34 ET | 800 | 20.685 |
| 12:36 ET | 779 | 20.7 |
| 12:38 ET | 100 | 20.71 |
| 12:39 ET | 800 | 20.695 |
| 12:41 ET | 1280 | 20.685 |
| 12:43 ET | 400 | 20.66 |
| 12:45 ET | 1200 | 20.73 |
| 12:48 ET | 1716 | 20.7 |
| 12:50 ET | 200 | 20.69 |
| 12:52 ET | 1775 | 20.75 |
| 12:54 ET | 200 | 20.75 |
| 12:56 ET | 1418 | 20.7 |
| 12:57 ET | 200 | 20.685 |
| 12:59 ET | 2736 | 20.75 |
| 01:01 ET | 1300 | 20.73 |
| 01:03 ET | 1020 | 20.71 |
| 01:06 ET | 500 | 20.73 |
| 01:08 ET | 1500 | 20.75 |
| 01:10 ET | 300 | 20.76 |
| 01:12 ET | 700 | 20.735 |
| 01:14 ET | 700 | 20.725 |
| 01:15 ET | 900 | 20.75 |
| 01:17 ET | 400 | 20.76 |
| 01:19 ET | 715 | 20.73 |
| 01:21 ET | 700 | 20.725 |
| 01:24 ET | 800 | 20.74 |
| 01:26 ET | 200 | 20.76 |
| 01:28 ET | 100 | 20.78 |
| 01:30 ET | 700 | 20.74 |
| 01:32 ET | 700 | 20.765 |
| 01:33 ET | 700 | 20.7 |
| 01:35 ET | 600 | 20.685 |
| 01:37 ET | 1461 | 20.73 |
| 01:39 ET | 700 | 20.715 |
| 01:42 ET | 1692 | 20.73 |
| 01:44 ET | 200 | 20.74 |
| 01:46 ET | 1103 | 20.7599 |
| 01:48 ET | 679 | 20.76 |
| 01:50 ET | 2278 | 20.71 |
| 01:51 ET | 300 | 20.735 |
| 01:53 ET | 729 | 20.72 |
| 01:55 ET | 1200 | 20.71 |
| 01:57 ET | 700 | 20.69 |
| 02:00 ET | 300 | 20.63 |
| 02:02 ET | 718 | 20.565 |
| 02:04 ET | 300 | 20.53 |
| 02:06 ET | 845 | 20.51 |
| 02:08 ET | 600 | 20.42 |
| 02:09 ET | 400 | 20.445 |
| 02:11 ET | 1529 | 20.45 |
| 02:13 ET | 907 | 20.405 |
| 02:15 ET | 1300 | 20.36 |
| 02:18 ET | 1415 | 20.39 |
| 02:20 ET | 858 | 20.43 |
| 02:22 ET | 3026 | 20.42 |
| 02:24 ET | 1064 | 20.385 |
| 02:26 ET | 1200 | 20.42 |
| 02:27 ET | 500 | 20.43 |
| 02:29 ET | 375 | 20.4414 |
| 02:31 ET | 300 | 20.45 |
| 02:33 ET | 1373 | 20.45 |
| 02:36 ET | 300 | 20.435 |
| 02:38 ET | 1972 | 20.48 |
| 02:40 ET | 1552 | 20.47 |
| 02:42 ET | 822 | 20.465 |
| 02:44 ET | 984 | 20.44 |
| 02:45 ET | 1200 | 20.425 |
| 02:47 ET | 4650 | 20.46 |
| 02:49 ET | 500 | 20.45 |
| 02:51 ET | 400 | 20.46 |
| 02:54 ET | 2992 | 20.48 |
| 02:56 ET | 1519 | 20.495 |
| 02:58 ET | 932 | 20.49 |
| 03:00 ET | 100 | 20.49 |
| 03:02 ET | 1458 | 20.47 |
| 03:03 ET | 1100 | 20.435 |
| 03:05 ET | 1220 | 20.465 |
| 03:07 ET | 1275 | 20.48 |
| 03:09 ET | 700 | 20.47 |
| 03:12 ET | 2264 | 20.5 |
| 03:14 ET | 400 | 20.48 |
| 03:16 ET | 923 | 20.49 |
| 03:18 ET | 1752 | 20.48 |
| 03:20 ET | 300 | 20.48 |
| 03:21 ET | 1725 | 20.5 |
| 03:23 ET | 1961 | 20.46 |
| 03:25 ET | 2063 | 20.46 |
| 03:27 ET | 1250 | 20.44 |
| 03:30 ET | 1477 | 20.46 |
| 03:32 ET | 2866 | 20.47 |
| 03:34 ET | 1826 | 20.5 |
| 03:36 ET | 3718 | 20.51 |
| 03:38 ET | 2529 | 20.53 |
| 03:39 ET | 3099 | 20.55 |
| 03:41 ET | 3664 | 20.55 |
| 03:43 ET | 2918 | 20.555 |
| 03:45 ET | 8284 | 20.52 |
| 03:48 ET | 2578 | 20.5 |
| 03:50 ET | 2332 | 20.495 |
| 03:52 ET | 6380 | 20.505 |
| 03:54 ET | 8462 | 20.56 |
| 03:56 ET | 9990 | 20.54 |
| 03:57 ET | 8308 | 20.52 |
| 03:59 ET | 273115 | 20.51 |
May 8, 2024
DJ Denali Therapeutics Is Maintained at Outperform by Wedbush, from 10:30AM ET on Wednesday May 08, 2024 by Dow Jones
10:30AM ET on Wednesday May 08, 2024 by Dow JonesDJ Denali Therapeutics Price Target Maintained With a $95.00/Share by HC Wainwright & Co., from 9:37AM ET on Wednesday May 08, 2024 by Dow Jones
9:37AM ET on Wednesday May 08, 2024 by Dow JonesDJ Denali Therapeutics Is Maintained at Hold by Stifel, from 9:37AM ET on Wednesday May 08, 2024 by Dow Jones
9:37AM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
*DJ Denali Therapeutics 1Q Loss/Shr 68c >DNLI, from 4:01PM ET on Tuesday May 07, 2024 by Dow Jones
4:01PM ET on Tuesday May 07, 2024 by Dow JonesDenali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights, from 4:01PM ET on Tuesday May 07, 2024 by Dow Jones
4:01PM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Denali Therapeutics Inc | 2.9B | -21.2x | --- |
Genmab A/S | 19.7B | 24.9x | +22.71% |
Maravai LifeSciences Holdings Inc | 2.9B | -11.4x | --- |
MorphoSys AG | 2.8B | -5.6x | --- |
Amicus Therapeutics Inc | 2.8B | -19.4x | --- |
Arrowhead Pharmaceuticals Inc | 3.1B | -5.8x | --- |
Company Information
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Contact Information
- Headquarters
- 161 Oyster Point BlvdSOUTH SAN FRANCISCO, CA, United States 94080-1910
- Phone
- 650-866-8548
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Vicki Sato
- President, Chief Executive Officer, Director
- Ryan Watts
- Chief Financial Officer, Chief Operating Officer, Company Secretary
- Alexander Schuth
- Chief Medical Officer
- Carole Ho
- Director
- Steven Krognes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $295.4M |
Shares Outstanding | 142.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.39 |
EPS | $-0.97 |
Book Value | $7.45 |
P/E Ratio | -21.2x |
Price/Sales (TTM) | 9.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -65.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
